Depo-Testosterone

Short answer For adult men, most professional guidelines use a total testosterone cutoff of about 300 ng/dL (≈10.4 nmol/L). If your morning total testosterone is consistently below ~300 ng/dL and you have compatible symptoms, treatment is usually considered. Below ~200 ng/dL (≈6.9 nmol/L) is more clearly “deficient.” Levels between roughly 200–300 ng/dL are borderline and need careful clinical judgment (symptoms, repeat tests, and possibly free testosterone). Why it isn’t just a number Treatment is recommended only when low lab values are combined with symptoms (reduced libido, erectile dysfunction, low energy, loss of muscle mass, depressed mood, decreased bone density, etc.). Many men with mildly low numbers and no symptoms are not treated. Labs vary by laboratory and assay method. Age and conditions that change sex‑hormone binding globulin (SHBG) — obesity, diabetes, thyroid disease — can make total testosterone misleading; in those cases free or bioavailable testosterone is helpful. How to get an accurate diagnosis Have total testosterone measured in the morning (usually before 10 a.m.), fasting if possible. If low, repeat the total testosterone on a separate day to confirm. If results are borderline or you have factors that affect SHBG, ask for free testosterone or calculated free testosterone and SHBG. Also check LH and FSH (to distinguish primary vs secondary hypogonadism), and consider prolactin, TSH, and other tests as indicated. Before starting treatment A clinician should evaluate for causes of low testosterone and screen for contraindications: prostate cancer (baseline PSA), polycythemia (baseline hematocrit), uncontrolled heart failure, uncontrolled severe sleep apnea, and clotting disorders. If started on testosterone, monitoring typically includes symptom response, testosterone levels, hematocrit, and PSA at intervals recommended by the treating clinician. Practical numbers and conversions Common cutoffs: <200 ng/dL = clearly low; 200–300 ng/dL = borderline; >300 ng/dL = usually not treated unless free T is low and symptoms present. Conversion: ng/dL × 0.0347 ≈ nmol/L. So 300 ng/dL ≈ 10.4 nmol/L. Treatment options (examples) Gels: AndroGel, Testim — steady daily dosing, easy to use but risk of transference to others. Injections: Testosterone cypionate or enanthate (often prescribed as Depo-Testosterone by clinicians) — less frequent dosing (weekly to every 2–3 weeks) and commonly used. Long‑acting injectable: Aveed — every 10–14 weeks after loading regimen (has specific administration rules). Nasal: Natesto — multiple daily doses, less risk of skin transfer. Choice depends on lifestyle, cost, side‑effect profile and monitoring needs; a clinician will help pick the best option. Where to get testing and care Standard labs: Quest Diagnostics or LabCorp for blood testing. For clinical evaluation and treatment you can see a primary care doctor, endocrinologist, or urologist. Telemedicine men’s health services (examples: Hims, Roman/Ro, Vault Health) offer testing and treatment pathways but it’s important they do a full evaluation and arrange proper monitoring. Next steps If you suspect low testosterone, make an appointment with your primary care physician or an endocrinologist/urologist. Bring symptoms you’ve noticed and ask for a morning total testosterone test (and repeat if low). If you’d like, tell me your lab value and symptoms and I can help interpret them and suggest questions to bring to your clinician.

Mentioned in position 3 of 10

Short answer If you want to preserve or restore fertility (or are trying to avoid testicular shrinkage), start with a drug that stimulates your own testosterone production — a SERM or hCG — before considered lifelong testosterone replacement therapy (TRT). If you have primary testicular failure (high LH), or very low testosterone with severe symptoms and no desire for future fertility, TRT is usually the appropriate first choice. Why (mechanisms & implications) Enclomiphene / clomiphene (SERMs): act at the hypothalamus/pituitary to raise LH/FSH and thereby increase your own testicular testosterone production. That preserves or often increases sperm production and testicular size. Good for secondary hypogonadism (low T with low/normal LH) and men who want children. TRT (injectable, gel, patch): supplies exogenous testosterone and reliably improves symptoms (energy, libido, mood, muscle). But TRT suppresses LH/FSH and usually reduces sperm production and causes testicular atrophy, so it harms fertility unless combined with hCG. Which clinical features point to one vs the other Consider SERM/hCG first if: You want to father children or maintain fertility Your labs show low T with low/normal LH (secondary hypogonadism) Testes are normal in size and you tolerate oral therapy Consider TRT first if: You have primary hypogonadism (low T with high LH) — testes can’t respond to LH stimulation You have very low T with significant symptoms and are not interested in fertility You want the most predictable symptomatic relief Practical notes, availability & examples Enclomiphene (brand: Androxal) was studied for male hypogonadism but is not widely available in routine clinical practice in many places. Because of that, many physicians use clomiphene citrate (brand names Clomid, Serophene) off‑label in men — it works similarly for raising endogenous T and is widely accessible and inexpensive. TRT options (brands/examples): injectable testosterone cypionate or enanthate (generic Depo‑Testosterone or pharmacy generics) — common and inexpensive; topical gels like AndroGel (AbbVie) or Testim — convenient but transfer risk to others; patches like Androderm — steady dosing but skin irritation in some men. If you need to be on TRT but want to preserve fertility, clinicians often add hCG (brands: Pregnyl, Novarel, recombinant Ovidrel) or use selective protocols with SERMs. Risks and monitoring SERMs (clomiphene/enclomiphene): possible mood changes, visual disturbance (rare), and increased clotting risk in susceptible people. Monitor testosterone, LH/FSH, and occasionally liver tests and symptoms. TRT: can cause erythrocytosis (monitor CBC), acne, sleep apnea worsening, testicular atrophy, and decreased sperm count; potential prostate‑related issues so monitor PSA and do periodic exams. Baseline labs before any therapy: morning total testosterone (repeat), LH, FSH, prolactin (if LH low), CBC, PSA (age-appropriate), and metabolic/cardiovascular assessment. Thresholds: symptomatic men with total testosterone consistently below ~300 ng/dL (morning, repeated) are commonly considered for treatment, but decisions must be individualized. Recommendation for next steps Get proper baseline testing (morning total T repeated, LH, FSH, prolactin, CBC, PSA as age-appropriate). See an endocrinologist or reproductive urologist to interpret whether your hypogonadism is primary vs secondary and discuss fertility plans. If fertility matters or LH is low/normal → discuss clomiphene/enclomiphene (or hCG) first. If primary hypogonadism or no fertility desire → discuss TRT (injectable or gel) as a first-line option. If cost/availability is a concern: clomiphene (Clomid) is a practical, commonly used alternative to enclomiphene; for TRT, generic testosterone cypionate injections are inexpensive and effective. If you want, tell me: Your latest morning total testosterone, LH/FSH, and whether you want children — I can give a more specific suggestion and list likely monitoring steps.

Mentioned in position 4 of 11

Short answer: For adult men the commonly used biochemical cutoff is a total testosterone below about 300 ng/dL (≈10.4 nmol/L). But treatment is usually recommended only when that low value is confirmed and the patient has symptoms consistent with testosterone deficiency. What clinicians actually do Measure total testosterone in the morning (ideally before 10 AM) on at least two separate days. Low values can fluctuate, so a single low test is not enough. If total testosterone is borderline (roughly 200–350 ng/dL) or if SHBG is abnormal (obesity, aging, thyroid disease, liver disease), many clinicians also check free or bioavailable testosterone. Treatment is usually offered when: (a) consistently low biochemical results AND (b) clinical symptoms such as low libido, erectile dysfunction, fatigue, loss of muscle mass/strength, increased body fat, depressed mood, or osteoporosis. Numbers to keep in mind Common lab cutoff: total testosterone <300 ng/dL (≈10.4 nmol/L). Markedly low values (for example <200 ng/dL) are more clearly diagnostic of hypogonadism, but symptoms and cause still matter. Additional tests and evaluation before treatment Repeat morning total testosterone. Measure LH and FSH to distinguish primary (testicular) vs secondary (pituitary/hypothalamic) hypogonadism. Check SHBG (to interpret total T), prolactin if secondary suspected, CBC, PSA and digital rectal exam (for older men), and assess cardiovascular risk factors. When not to treat (examples) Known or suspected prostate cancer, untreated severe urinary obstruction, untreated polycythemia (hematocrit >50%), or certain uncontrolled cardiac conditions. Treatment decisions should be individualized. Common replacement options (examples) Topical gels: AndroGel, Testim — convenient, steady dosing, risk of skin transfer to others. Injections: testosterone cypionate or enanthate (often dispensed as Depo‑Testosterone or generic preparations) — inexpensive and effective; injections can be given every 1–3 weeks (bursts in levels). Nasal: Natesto — alternative for people who prefer nontransdermal, lower transfer risk. Patches: Androderm — steady delivery but skin irritation can occur. Pellets: Testopel (inserted under the skin by a clinician) — long acting but requires minor procedure. Choice depends on preferences, cost, comorbidities, and monitoring ability. Where to get testing/treatment (examples) Lab testing: Quest Diagnostics or Labcorp — large national labs with morning appointments and reliable assays. At‑home testing: companies like Everlywell offer convenient kits, but low or borderline results should be confirmed by a clinician with formal lab testing. Clinical care: see your primary care doctor, a urologist, or an endocrinologist. Telemedicine services such as Roman (Ro) or Hims offer streamlined evaluation and treatment options for men’s health, but make sure they do appropriate testing and follow‑up. Monitoring if you start therapy Recheck testosterone levels (to ensure in therapeutic range), hematocrit/hemoglobin (to monitor for polycythemia), PSA and prostate exam per guidelines, and periodic assessment of symptoms and adverse effects. Bottom line A lab value alone won’t “require” treatment — the usual cutoff is total testosterone <300 ng/dL, but clinicians treat only after confirming low levels and documenting symptoms, ruling out reversible causes, and discussing benefits/risks. Talk with your primary care doctor or an endocrinologist/urologist to get appropriate morning testing and individualized recommendations. If you want, I can: Help locate nearby Quest or Labcorp locations for morning testing, or Explain advantages/disadvantages of specific formulations (gel vs injection vs nasal) for your situation.

Mentioned in position 3 of 11

Short answer: TRT can help symptoms of low testosterone (low energy, low libido, low muscle mass) but it carries significant risks — especially for men in their 30s who may still want biological children. Before starting, get a full evaluation by an endocrinologist or urologist, discuss fertility plans, and plan careful monitoring. Key risks and side effects Reduced fertility / sperm count and testicular shrinkage: Exogenous testosterone suppresses gonadotropins (LH/FSH), often causing decreased sperm production and testicular atrophy. This can be reversible but may take many months to years; in some cases fertility problems persist. If you want children, do not start TRT without discussing alternatives or sperm banking. Decreased natural testosterone production: Often lifelong dependence on replacement once the hypothalamic–pituitary–gonadal (HPG) axis is suppressed. Increased red blood cell mass (polycythemia): TRT can raise hematocrit, increasing risk of blood clots, stroke, and heart attack if not monitored/managed. Cardiovascular concerns: Data are mixed. Some studies suggest increased CV risk in certain groups (older or with preexisting heart disease); causation is uncertain but you should evaluate heart risk factors beforehand. Mood and behavior changes: Improved mood and libido are common, but some men experience irritability, aggression, or mood swings — particularly with injectable regimens that produce peaks and troughs. Sleep apnea: TRT can worsen or unmask obstructive sleep apnea. Skin changes and local problems: Acne, oily skin; with topical products there’s a risk of transference to partners/children. Gynecomastia: Some testosterone aromatizes to estrogen and can cause breast tissue enlargement unless controlled. Prostate effects: TRT raises PSA in some men and can enlarge the prostate; TRT is contraindicated if active prostate cancer is known (the relationship with long‑term prostate cancer risk is uncertain). Baseline PSA and monitoring are recommended. Liver effects: Oral anabolic steroids can be hepatotoxic; marketed TRT options are usually not the same toxic oral steroids, but liver tests are sometimes checked. Other: Changes in lipids, possible infertility counseling/legal/insurance considerations. Monitoring and workup before/while on TRT Baseline tests: morning total testosterone (two measurements), free testosterone (or calculated), LH, FSH, prolactin, CBC (hematocrit), CMP (liver, kidney), fasting lipids, and baseline PSA (if appropriate). Screen for sleep apnea if risk factors. Follow-up: check testosterone and hematocrit in ~3 months after starting/dose change, then 6 months, then annually. PSA and lipids periodically. More frequent CBC monitoring if hematocrit rises. If hematocrit >54% or rapidly increasing, TRT should be paused/adjusted and phlebotomy considered. Fertility-preserving options and alternatives If you want children: consider sperm banking (cryopreservation) before starting TRT. Alternatives that preserve fertility or stimulate endogenous production: clomiphene citrate (Clomid) or hCG injections (brands include Pregnyl, Novarel or recombinant Ovitrelle/Ovidrel) can raise testosterone by stimulating the HPG axis; they are used off‑label for “low T” in men who want to maintain fertility. These require specialist oversight. Shorter-acting options and different routes (topical gels, nasal Natesto, injections, or pellets like Testopel) have different pros/cons for convenience, absorption, transfer risk, and HPG suppression. Formulations / brand examples Injections: testosterone cypionate (Depo-Testosterone is a brand) or generic testosterone enanthate (common, inexpensive). Gels/creams: AndroGel, Testim, Fortesta, Axiron — steady absorption but risk of skin-to-skin transfer. Nasal: Natesto (nasal gel) — less risk of transfer; dosing more frequent. Patches: Androderm. Pellets: Testopel (implanted under the skin; minor procedure). Note: choice of formulation affects side‑effect profile, convenience, and cost. Who to see and services to consider Specialists: see a board‑certified endocrinologist or urologist with experience in male reproductive endocrinology. They’ll assess cause of low T, fertility issues, and safety. Telemedicine/men’s health services: companies like Roman (Ro), Hims, and Lemonaid provide convenience but vary in the thoroughness of evaluation. If you use them, ensure they do full lab testing and appropriate monitoring. Labs and sperm banking: use established labs (Quest Diagnostics, LabCorp) for testing; for sperm banking, local fertility clinics or established banks (e.g., Cryos International) can provide cryopreservation. Avoid black‑market testosterone or unregulated compounds. Practical steps before you start Get a careful evaluation and repeat morning testosterone test plus LH/FSH and other labs. Identify treatable causes (sleep apnea, obesity, meds, thyroid). Discuss fertility plans. If you may want children, consider sperm banking or alternatives (clomiphene/hCG). Discuss risks, benefits, and preferred formulation with a specialist. Start with a monitored trial if appropriate, with baseline labs and scheduled follow-up (CBC, testosterone, PSA/lipids). Reassess symptoms and labs at ~3 months; adjust or stop as needed. If you want, tell me: Are you experiencing symptoms (low libido, fatigue, low muscle mass)? Any recent lab results? Do you want children in the future? I can suggest next lab tests to request and which specialist to contact.

Mentioned in position 6 of 19

Short answer In adult men, treatment is usually considered only when a man has clear symptoms of low testosterone and consistently low morning total testosterone — typically below about 300 ng/dL (about 10.4 nmol/L). Guidelines (Endocrine Society) use ~300 ng/dL as the commonly cited cutoff. What “low” means in practice You need both: compatible symptoms (low libido, erectile problems, fatigue, loss of muscle mass, depressed mood, decreased bone density, etc.) and unequivocally low lab values. Most clinicians consider: <200 ng/dL (≈6.9 nmol/L): clearly low and usually treated if symptomatic. 200–300 ng/dL (≈6.9–10.4 nmol/L): borderline — interpret with symptoms and consider measuring free testosterone and further evaluation. 300 ng/dL: usually not considered biochemical hypogonadism unless free testosterone is low or lab/reference ranges differ. Important testing details Measure total testosterone in the morning (ideally 7–10 AM), fasting, and repeat the test on a different day to confirm low levels. If total testosterone is borderline or SHBG (sex hormone–binding globulin) is abnormal (e.g., obesity, diabetes, thyroid disease), measure or calculate free testosterone. Also check LH (to distinguish primary vs secondary hypogonadism), prolactin (if LH is low), and other relevant tests (CBC, PSA baseline in older men, metabolic panel) before starting therapy. Other considerations and risks Don’t treat based on numbers alone — treatment is for symptomatic men after workup. Testosterone therapy can suppress sperm production and reduce fertility; if you want fertility, discuss alternatives (clomiphene, hCG) with a specialist. Monitor therapy for hematocrit (risk of erythrocytosis), PSA/prostate health, symptoms, and testosterone level adjustments. For older men with age-related decline, guidelines recommend caution and individualized decision-making — not automatic treatment. Next steps I recommend If you have symptoms: get two morning total testosterone tests (Quest Diagnostics or LabCorp are common nationwide labs). If low, ask your doctor for LH, prolactin and SHBG/free T, plus baseline CBC and PSA as appropriate. If you want, tell me your symptoms and any lab values you already have and I can help interpret them and suggest specific next steps. If you later consider therapy, common formulations (talk to your clinician about pros/cons): Topical gels: AndroGel, Testim — easy daily dosing, variable transfer risk to others. Patches: Androderm — nightly patch. Intramuscular injections: testosterone cypionate (Depo‑Testosterone/generic) — typically every 1–2 weeks; testosterone undecanoate (Aveed / Nebido depending on country) is long‑acting. Subcutaneous pellets: Testopel — implanted every few months. All medication choices should be guided by a clinician after confirming low levels and discussing risks, fertility goals, and monitoring plans.

Mentioned in position 6 of 9

Short answer Starting testosterone replacement therapy (TRT) in your 30s can relieve low‑T symptoms (low energy, low libido, low muscle mass) but carries several important risks — most importantly suppression of fertility and testicular atrophy — plus possible cardiovascular, hematologic, prostate, sleep, skin, and mood effects. Because you’re in your 30s, fertility preservation and specialist evaluation are especially important. Main risks and side effects Fertility suppression and testicular atrophy: Exogenous testosterone suppresses LH/FSH → markedly lowers sperm production. This commonly causes reduced sperm count and can lead to infertility while on therapy. Testicular shrinkage is common. Recovery after stopping can take months to over a year and is not guaranteed. If you want children, consider sperm banking first or use fertility‑sparing alternatives (see below). Reduced sperm count is often rapid: declines can begin in weeks and are usually substantial within months. Polycythemia (increased red blood cell mass): TRT frequently raises hemoglobin/hematocrit, raising risk of blood clots, stroke, and heart attack if hematocrit gets too high. Cardiovascular risk: data are mixed. Some studies show increased risk of heart attack/stroke in certain populations, especially older men or those with preexisting heart disease. The absolute risk in healthy younger men is less clear, but it’s something to discuss with your clinician. Prostate effects: TRT increases PSA and can worsen benign prostatic hyperplasia (BPH). Current evidence does not convincingly show TRT causes prostate cancer, but baseline screening and monitoring are standard practice. Sleep apnea: TRT can worsen or unmask obstructive sleep apnea. Skin and breast changes: acne, oily skin, and sometimes gynecomastia (via aromatization to estrogen). Mood and behavior changes: irritability, aggression, or mood swings in some men. Fluid retention and increased blood pressure in some users. Liver effects: rare with injectable/gels; oral 17‑alkylated androgens (not commonly used for TRT) are hepatotoxic. Injection‑site or application‑site reactions for injectables, gels, and patches. Who should not start TRT (common contraindications) Known or suspected prostate cancer or male breast cancer Uncontrolled severe heart failure or uncontrolled cardiovascular disease (discuss with cardiologist) Hematocrit significantly elevated at baseline (>50%) Untreated severe obstructive sleep apnea Men who want to maintain fertility unless using fertility‑sparing strategies Fertility preservation and alternatives If you plan to father children, strongly consider sperm banking/cryopreservation before starting TRT. Fertility‑preserving medical options: Human chorionic gonadotropin (hCG) (used to stimulate testicular testosterone and maintain spermatogenesis) — preserves testicular function when used with or instead of testosterone. Selective estrogen receptor modulators (SERMs) such as clomiphene citrate (Clomid) to raise endogenous LH/testosterone while preserving fertility in some men. Aromatase inhibitors (anastrozole/Arimidex, letrozole/Femara) in specific cases (used under specialist guidance). These are typically prescribed and monitored by a urologist or reproductive/endocrine specialist. Monitoring and baseline tests (typical) Baseline: total testosterone (morning), free testosterone if indicated, LH/FSH, prolactin, CBC (hematocrit/hemoglobin), PSA, lipid panel, liver enzymes, fasting glucose or HbA1c, and sleep‑apnea screen if suggestive. Ongoing: testosterone level after dose adjustment (timing depends on formulation), CBC every 3–6 months for the first year then annually, PSA at 3–6 months then per urology guidance, lipids and liver enzymes periodically, and regular symptom review. Watch for hematocrit >54% (often considered threshold for treatment changes/therapeutic phlebotomy). Treatment forms and example brands (common options) Topical gels: AndroGel, Testim — convenient daily dosing, can transfer to partners/children if contact with application site; monitor levels. Transdermal patch: Androderm — daily patch, can cause skin irritation. Intramuscular injections: Depo‑Testosterone (testosterone cypionate), generic testosterone enanthate — cheaper, given every 1–3 weeks (shorter acting) or on prescribed schedules; peaks and troughs possible. Long‑acting injectable: Aveed (testosterone undecanoate) or Nebido (testosterone undecanoate in non‑US markets) — longer interval dosing (e.g., every 10–14 weeks) and steadier levels for some. Subcutaneous pellets: Testopel — implanted pellets lasting months; requires minor procedure. Note: choice depends on lifestyle, cost, side‑effect profile, and monitoring needs; discuss with your clinician. Fertility‑preserving drug names to discuss with a specialist Clomiphene citrate (Clomid) — raises endogenous testosterone without suppressing spermatogenesis in many men. Recombinant or urinary hCG (brands such as Ovidrel use choriogonadotropin alfa for some fertility indications; Pregnyl and Novarel are other hCG brands) — used to maintain intratesticular testosterone and sperm production. Anastrozole (Arimidex) or letrozole (Femara) — aromatase inhibitors in select cases. When to seek urgent care Symptoms of blood clots (leg swelling/pain), sudden chest pain, sudden shortness of breath, severe headache or vision changes, or very high blood pressure. Bottom line and recommended next steps Don’t start TRT without a medical workup. See an endocrinologist or urologist experienced in male reproductive health. If you want children, prioritize sperm banking and discuss fertility‑preserving regimens (hCG, clomiphene) before starting testosterone. Get baseline labs (testosterone, LH/FSH, CBC, PSA, lipids, LFTs) and arrange a monitoring schedule. Weigh formulation pros/cons (gels vs injections vs long‑acting vs pellets) with your clinician. If you’re considering TRT, ask directly about cardiovascular risk in your personal profile and any underlying conditions. If you want, tell me whether preserving fertility is a priority for you and whether you have any known medical conditions (heart disease, sleep apnea, elevated hematocrit, prostate issues). I can then outline a personalized checklist and the most appropriate specialists to consult.

Mentioned in position 4 of 10